Vermillion S T, Soper D E, Newman R B
Department of Obstetrics and Gynecology, Medical University of South Carolina, Charleston, SC 29425, USA.
Am J Obstet Gynecol. 2000 Oct;183(4):810-4. doi: 10.1067/mob.2000.108838.
This study was undertaken to compare the effects of single versus multiple courses of betamethasone therapy on the frequencies of neonatal outcomes and perinatal infectious morbidity among singleton pregnancies complicated by preterm delivery.
We performed a nonconcurrent prospective analysis of singleton pregnancies delivered between 24 and 34 weeks' gestation after antenatal betamethasone exposure. Patients were categorized into two groups according to betamethasone exposure: (1) two 12-mg doses in a 24-hour interval on admission (single-course group) and (2) repeated dosing after the initial single course (multiple-course group). All patients received prophylactic antibiotics for group B streptococci. Any patients with ruptured membranes for >24 hours before delivery were excluded. Data were analyzed with the Student t test, the chi(2) test, and the Fisher exact test. Multiple logistic regression analyses were performed to examine the effect of each steroid dosing regimen on early-onset neonatal sepsis and neonatal death. P <.05 was considered significant for all 2-tailed tests.
A total of 453 patients were included, with 267 in the single-course group and 186 in the multiple-course group. The two groups were similar with respect to maternal demographic characteristics, gestational age at delivery, mode of delivery, birth weight, and maternal group B streptococcal colonization. Multiple courses were significantly associated with early-onset neonatal sepsis (odds ratio, 5.00; 95% confidence interval, 1.3-23. 2), chorioamnionitis (odds ratio, 9.96; 95% confidence interval, 2. 1-64.6), endometritis (odds ratio, 3.61; 95% confidence interval, 1. 7-8.1), and neonatal death (odds ratio, 2.92; 95% confidence interval, 1.3-6.9). The frequencies of the other neonatal outcomes analyzed, including respiratory distress syndrome and grade III or IV intraventricular hemorrhage, were similar between the 2 groups. Multiple logistic regression analyses confirmed that multiple courses of antenatal betamethasone were independently associated with early-onset neonatal sepsis (odds ratio, 1.25; 95% confidence interval, 1.1-1.9) and neonatal death (odds ratio, 1.70; 95% confidence interval, 1.1-1.9).
Multiple courses of antenatal betamethasone are associated with increased risks of perinatal infectious morbidity and neonatal death.
本研究旨在比较单疗程与多疗程倍他米松治疗对单胎妊娠合并早产新生儿结局频率及围产期感染性发病率的影响。
我们对产前接受倍他米松治疗后在孕24至34周分娩的单胎妊娠进行了非同期前瞻性分析。根据倍他米松暴露情况将患者分为两组:(1)入院时在24小时内给予两剂12毫克(单疗程组);(2)在初始单疗程后重复给药(多疗程组)。所有患者均接受B族链球菌预防性抗生素治疗。排除分娩前胎膜破裂超过24小时的任何患者。数据采用Student t检验、卡方检验和Fisher精确检验进行分析。进行多因素逻辑回归分析以检验每种类固醇给药方案对早发性新生儿败血症和新生儿死亡的影响。所有双侧检验中P <.05被认为具有统计学意义。
共纳入453例患者,单疗程组267例,多疗程组186例。两组在产妇人口统计学特征、分娩时孕周、分娩方式、出生体重和产妇B族链球菌定植方面相似。多疗程与早发性新生儿败血症(比值比5.00;95%置信区间1.3 - 23.2)、绒毛膜羊膜炎(比值比9.96;95%置信区间2.1 - 64.6)、子宫内膜炎(比值比3.61;95%置信区间1.7 - 8.1)和新生儿死亡(比值比2.92;95%置信区间1.3 - 6.9)显著相关。分析的其他新生儿结局频率,包括呼吸窘迫综合征和III或IV级脑室内出血,两组之间相似。多因素逻辑回归分析证实,产前多疗程倍他米松与早发性新生儿败血症(比值比1.25;95%置信区间1.1 - 1.9)和新生儿死亡(比值比1.70;95%置信区间1.1 - 1.9)独立相关。
产前多疗程倍他米松与围产期感染性发病率和新生儿死亡风险增加相关。